MRNA

Welcome to the Brand page for “MRNA”, which is offered here for The mark consists of the greek letter chi to the left of the standard letters mrna without claim to any particular font, style, size or character.;a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, nucleic acid therapeutics for the treatment of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, gastroenterological disorders, ocular disorders or diseases, bacteria-based diseases, diabetes, cancer, oncology, immunoregulartory disorders, infectious disorders, reproductive disorders, cardiovascular disorders; for use in dermatology, oncology, nephrology, hematology, ophthalmology, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and in tissue and organ transplantation;color is not claimed as a feature of the mark.;scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “MRNA” is believed to be currently owned by “Moderna Therapeutics, Inc.”